N-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)-2-(4-methylpiperidin-1-yl)acetamide

ID: ALA4087137

PubChem CID: 39070423

Max Phase: Preclinical

Molecular Formula: C20H21N3O3

Molecular Weight: 351.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC1CCN(CC(=O)NN2C(=O)c3cccc4cccc(c34)C2=O)CC1

Standard InChI:  InChI=1S/C20H21N3O3/c1-13-8-10-22(11-9-13)12-17(24)21-23-19(25)15-6-2-4-14-5-3-7-16(18(14)15)20(23)26/h2-7,13H,8-12H2,1H3,(H,21,24)

Standard InChI Key:  MEXGQNLBAWNRDM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
   39.8470   -1.3908    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8458   -2.2145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5562   -0.9820    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2648   -1.3872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6906   -2.2066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6859   -1.3804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9727   -0.9770    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2656   -2.2104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5584   -2.6225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.5582   -3.4385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.2634   -3.8486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9747   -3.4406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9766   -2.6184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.8456   -3.8459    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.6860   -3.8501    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.2620   -4.6699    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   41.9732   -5.0838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.9718   -5.9051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.6857   -4.6723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.6829   -6.3149    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.6760   -7.1369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3831   -7.5507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.0980   -7.1427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1014   -6.3204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.3898   -5.9062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8076   -7.5593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  9  1  0
  4  3  2  0
  3  1  1  0
  4  8  1  0
 13  5  2  0
  5  6  1  0
  6  7  2  0
  7  4  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 10 14  2  0
 12 15  2  0
 11 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  1  0
 20 25  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 23 26  1  0
M  END

Associated Targets(non-human)

CV-1 (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vaccinia virus (4609 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 351.41Molecular Weight (Monoisotopic): 351.1583AlogP: 2.20#Rotatable Bonds: 3
Polar Surface Area: 69.72Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.78CX Basic pKa: 6.89CX LogP: 2.12CX LogD: 2.00
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.86Np Likeness Score: -1.22

References

1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A..  (2017)  Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents.,  27  (16): [PMID:28666733] [10.1016/j.bmcl.2017.06.035]

Source